Provided by Tiger Trade Technology Pte. Ltd.

WAVE Life Sciences

4.59
-0.0800-1.71%
Post-market: 4.650.0600+1.31%17:55 EDT
Volume:2.21M
Turnover:10.15M
Market Cap:904.23M
PE:-4.26
High:4.72
Open:4.67
Low:4.56
Close:4.67
52wk High:21.73
52wk Low:4.56
Shares:197.00M
Float Shares:94.77M
Volume Ratio:0.59
T/O Rate:2.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0766
EPS(LYR):-1.2118
ROE:-67.42%
ROA:-33.60%
PB:1.99
PE(LYR):-3.79

Loading ...

Wave Life Sciences price target lowered to $18 from $28 at Jefferies

TIPRANKS
·
Mar 27

Wave Life Sciences Down Over 49%, On Pace for Largest Percent Decrease Since December 2019 -- Data Talk

Dow Jones
·
Mar 27

Wave data brings questions about Arrowhead ‘back to center stage,’ says Leerink

TIPRANKS
·
Mar 26

Wave Life Sciences falls -57.6%

TIPRANKS
·
Mar 26

Wave Life Sciences Shares Down 56% as Obesity Drug Fails to Show Promise in Early-Stage Trial

THOMSON REUTERS
·
Mar 26

BUZZ-U.S. STOCKS ON THE MOVE-Corebridge, Robinhood, Navan

Reuters
·
Mar 26

Wave Life Sciences Says Obesity Drug Improved Body Composition in Study

Dow Jones
·
Mar 26

Wave Life Sciences Shares Plunge 54% Premarket After Co Reports Obesity Drug Early-Stage Trial Data

THOMSON REUTERS
·
Mar 26

Wave Life Sciences Ltd - to Initiate Phase 2a Inlight and New Wve-007 Trials as Incretin Add-on in 2026

THOMSON REUTERS
·
Mar 26

Wave Life Sciences Ltd: Additional Data From Inlight, Including Data From 600 Mg Phase 1 Sad Cohort, Are Expected in 2026

THOMSON REUTERS
·
Mar 26

Wave Life Sciences Ltd - Wve-007 Continues to Be Generally Safe and Well Tolerated

THOMSON REUTERS
·
Mar 26

Wave Life Sciences reports Phase 1 INLIGHT interim data; WVE-007 cuts visceral fat 14.3% at 6 months after a single 240 mg dose

Reuters
·
Mar 26

Wave Life Sciences Ltd : Mizuho Raises Target Price to $27 From $22

THOMSON REUTERS
·
Mar 25

Mizuho Securities Reaffirms Their Buy Rating on Wave Life Sciences (WVE)

TIPRANKS
·
Mar 25

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Pfizer (PFE) and Wave Life Sciences (WVE)

TIPRANKS
·
Mar 24

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE), Wave Life Sciences (WVE) and Telix Pharmaceuticals (OtherTLPPF)

TIPRANKS
·
Mar 16

Wave Life Sciences Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Mar 11

Wave Life Sciences price target raised to $52 from $43 at Canaccord

TIPRANKS
·
Mar 10

Wave Life Sciences Ltd : Canaccord Genuity Raises Target Price to $52 From $43

THOMSON REUTERS
·
Mar 10